[HTML][HTML] Diaphragmatic dysfunction

J Ricoy, N Rodríguez-Núñez, JM Álvarez-Dobaño… - Pulmonology, 2019 - Elsevier
The diaphragm is the main breathing muscle and contraction of the diaphragm is vital for
ventilation so any disease that interferes with diaphragmatic innervation, contractile muscle …

[HTML][HTML] Practical approach to respiratory emergencies in neurological diseases

F Racca, A Vianello, T Mongini, P Ruggeri… - Neurological …, 2020 - Springer
Many neurological diseases may cause acute respiratory failure (ARF) due to involvement of
bulbar respiratory center, spinal cord, motoneurons, peripheral nerves, neuromuscular …

Respiratory involvement in patients with neuromuscular diseases: a narrative review

A Voulgaris, M Antoniadou, M Agrafiotis… - Pulmonary …, 2019 - Wiley Online Library
Respiratory muscle weakness is a major cause of morbidity and mortality in patients with
neuromuscular diseases (NMDs). Respiratory involvement in NMDs can manifest broadly …

[HTML][HTML] Recommendations for infantile-onset and late-onset Pompe disease: An Iranian consensus

F Fatehi, MR Ashrafi, M Babaee, B Ansari… - Frontiers in …, 2021 - frontiersin.org
Background: Pompe disease, also denoted as acid maltase or acid α-glucosidase deficiency
or glycogen storage disease type II, is a rare, autosomal recessive lysosomal storage …

[HTML][HTML] A Comprehensive Update on Late-Onset Pompe Disease

B Labella, S Cotti Piccinelli, B Risi, F Caria, S Damioli… - Biomolecules, 2023 - mdpi.com
Pompe disease (PD) is an autosomal recessive disorder caused by mutations in the GAA
gene that lead to a deficiency in the acid alpha-glucosidase enzyme. Two clinical …

Monitoring and Management of Respiratory Function in Pompe disease: current perspectives

L El Haddad, M Khan, R Soufny, D Mummy… - … and Clinical Risk …, 2023 - Taylor & Francis
Pompe disease (PD) is a neuromuscular disorder caused by a deficiency of acid alpha-
glucosidase (GAA)–a lysosomal enzyme responsible for hydrolyzing glycogen. GAA …

[HTML][HTML] Molecular pathways and respiratory involvement in lysosomal storage diseases

P Faverio, A Stainer, F De Giacomi, S Gasperini… - International journal of …, 2019 - mdpi.com
Lysosomal storage diseases (LSD) include a wide range of different disorders with variable
degrees of respiratory system involvement. The purpose of this narrative review is to treat …

Inhibitory effect of raspberry ketone on α-glucosidase: Docking simulation integrating inhibition kinetics

SL Xiong, LM Yue, GT Lim, JM Yang, J Lee… - International journal of …, 2018 - Elsevier
Inhibition of α-glucosidase is directly associated with treatment of type 2 diabetes. In this
regard, we conducted enzyme kinetics integrated with computational docking simulation to …

Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

C Papadopoulos, D Orlikowski, H Prigent… - Molecular Genetics and …, 2017 - Elsevier
Background The efficacy of enzyme replacement therapy (ERT) in patients at an advanced
stage of Pompe disease has only been addressed in a few studies. Our objective was to …

[HTML][HTML] Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective

S Erdem Ozdamar, AF Koc, H Durmus Tekce… - Frontiers in …, 2023 - frontiersin.org
This consensus statement by a panel of neurology experts aimed to provide a practical and
implementable guidance document to assist clinicians with the best clinical practice in terms …